Continuation or discontinuation of oxytocin during the active first stage of labor (≥6 cm dilation). for Induced Birth
Study Summary
This trial is testing whether or not stopping oxytocin during labor will reduce the number of c-sections.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 10 Secondary · Reporting Duration: Within 28 days of delivery
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Intervention site (Foothills Medical Centre): Continuation of Oxytocin
1 of 2
Intervention site (Foothills Medical Centre): Discontinuation of oxytocin
1 of 2
Experimental Treatment
Non-Treatment Group
200 Total Participants · 2 Treatment Groups
Primary Treatment: Continuation or discontinuation of oxytocin during the active first stage of labor (≥6 cm dilation). · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is the research team currently recruiting volunteers for this trial?
"According to the information about this trial on clinicaltrials.gov, the study is presently looking for suitable candidates. It was initially published on October 25th 2021 and its details were most recently updated that same day." - Anonymous Online Contributor
What objectives has this clinical trial been designed to fulfill?
"This clinical trial is set to assess the rate of Cesarean section during labour, following a dilation threshold of 6cm or more. Secondary outcomes being monitored include perinatal death, postpartum haemorrhage and neonatal asphyxia in primiparous women delivering at term (37 weeks gestation) with singleton vertex-presenting foetuses. The latter involves intrapartum stillbirths, neonatal mortality from asphyxiation or intensive care unit admissions coupled with Apgar scores lower than 5 after 10 minutes, mechanical ventilation/chest compressions for resuscitation within 10 minutes and cord pH" - Anonymous Online Contributor
What is the most frequent application of continuing or halting oxytocin during active first stage labor (≥6 cm dilation)?
"Oxytocin can be administered or withheld to manage the labour process, including controlling haemorrhage, uterine contractions, and childbirth." - Anonymous Online Contributor
How many subjects are being monitored within this research trial?
"Affirmative. Information on the clinicaltrials.gov website shows that this research is currently in search of participants, having been listed since October 25th 2021 with no updates to date. 200 individuals are needed from a single location for it's completion." - Anonymous Online Contributor